Navigation Links
Aethlon Medical Releases Shareholder Letter
Date:11/16/2011

e Medanta study would contribute to improving shareholder value.  We were wrong.  Study delays, including protocol changes, patient recruitment challenges, and other mishaps instead contributed to an erosion of shareholder value. That said, I want to reinforce that there has been no indication that our Hemopurifier® isn't performing in the manner we had expected.

Certain delays may prove to be beneficial.  On July 19th, we met with FDA to discuss a proposal to initiate Hemopurifier® clinical studies in the U.S.  During our meeting, we were asked if it was possible to measure the quantity of virus captured within the Hemopurifier® during treatment?  Our answer was yes, as our science team had measured this data point on three previous occasions.  Normally, our focus is to measure viral load changes in patient blood to quantify the potential for benefit.  In response to FDA's question, we modified our Medanta study protocol so that we could incorporate this secondary data point in a revised IDE submission to FDA.  With this change in place, our protocol is now being administered to enrolled patients at the Medanta Medicity Institute.  Our primary endpoint goal remains to demonstrate that our Hemopurifier® improves both immediate and rapid viral response rates when combined with interferon versus interferon alone.  We remain convinced that our Hemopurifier® will offer an enduring opportunity to improve current and future iterations of HCV drug therapies.  However, with the advent of the Aethlon ADAPT™ system, we have transitioned to being revenue stage organization whose value should no longer be attributed to one product application.  On behalf of our dedicated team at Aethlon Medical, I thank you for your continued support.

Very truly yours,

James A. Joyce
Chairman, CEO

Certain of the statements herein may be forward-looking and inv
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th
2. Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community
3. Aethlon Medical Announces Hemopurifier® and HER2osome™ Cancer Therapy Presentation at Exosomes and Microvesicles 2011
4. "A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression" Released by Aethlon Medical, Inc.
5. Aethlon Medical Introduces HER2osome™, A Novel Therapeutic Device Strategy to Address Breast Cancer
6. Aethlon Medical Releases Shareholder Letter
7. Aethlon Medical to Discuss Recent Progress at the LHA Life Sciences & Medical Technologies Virtual Conference on June 16
8. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
9. Aethlon Medical Clarifies News Report
10. ABC News Reports on Aethlon Medical
11. Aethlon Medical Announces Multi-Target Exosome Assay Validation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... EAST RUTHERFORD, N.J., May 1, 2015 Cambrex Corporation ... ended March 31, 2015. Highlights ... 2014, and increased 27% excluding foreign currency impact, driven by ... $18.0 million from $8.4 million in the first quarter of ... $0.26 versus $0.04 in the first quarter last year and ...
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - Pivotal ... pharmaceutical company with a focus on Omega-3 therapies ... its operational highlights and financial results for the ... amounts referenced herein are in Canadian dollars unless ... have been significant, with the right strategic partners ...
(Date:4/30/2015)... 2015 Omnicell, Inc. (NASDAQ: OMCL ), a ... healthcare systems, today announced results for its first quarter ... for the first quarter of 2015 was $116.2 million, ... of 2014, and down $5.3 million or 4.4% from ... 2015 net income as reported in accordance with U.S. ...
Breaking Medicine Technology:Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21
(Date:5/2/2015)... 02, 2015 With the success that Veatch ... proud to welcome Neida Miranda and Alex Shields to the ... has over 41 years of combined experience working with dentists ... the dental field for 8 years. She was certified ... Texas. Customer service, positive attitude and showing the importance of ...
(Date:5/1/2015)... Providenciales, Turks and Caicos Islands, BWI (PRWEB) May 02, ... has a new website! It is http://www.thevenetiangracebay.com ... resort itself, and it incorporates the stunning white and ... "According to a study of Google, sixty seven percent ... process. The study showed that smartphones were used ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Jusuru International ... for the successful repositioning of its flagship nutritional supplement, ... brand with a new name, new logo, new packaging, ... Ethos Awards are designed to identify and promote programs ... best. , “DSA congratulates Jusuru International for their ...
(Date:5/1/2015)... May 01, 2015 The Workgroup ... nonprofit authority on the use of health IT to ... key contributing resource to the United States Government Accountability ... electronically readable cards in Medicare. The report, “ Potential ... ” was released to the public on Apr. 24, ...
(Date:5/1/2015)... 2015 It’s raining bills on Capitol Hill ... to expand federal support for telemedicine. , “Such ... been working with Congress,” said Jonathan Linkous, CEO of the ... nation is poised to embrace the use of telecommunications in ... in fulfilling ATA’s mission to improve quality, access, equity and ...
Breaking Medicine News(10 mins):Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... Lancet (vol. 370, 11 August 2007) could lead to a ... It states that magnetic resonance imaging (MRI) is substantially more ... cancer . Up to now MRI was thought to be ... situ (DCIS) . Researchers at the University of Bonn have ...
... increase according to stage of disease, a new study ... CANCER, a peer-reviewed journal of the American Cancer Society, ... each stage, African American women had larger tumors and ... to nearby lymph nodes. After controlling for those clinical ...
... Today’s report from the Food and Drug Administration (FDA) ... forward in the agency’s effort to tackle the new ... The Task Force is clear and candid in acknowledging ... product category FDA regulates—from pharmaceuticals and devices to cosmetics ...
... by researchers at the University of Southern California, has brought ... the genetic changes that enable tumours to evade the body's ... breast and colorectal cancers, are significant to the field of ... tests and treatment for cancers. ,"The implication is ...
... baby to be produced from an egg, that was developed in ... ,The news provides hope for women who have ... help egg maturation in the ovaries themselves. ,The baby ... Canada after work at the McGill Reproductive Centre in Montreal. The ...
... community is struggling to come to terms with the aftermath of ... are emerging. ,An al-Qaeda leader in Iraq may ... when he reportedly told a British cleric in Baghdad that "those ... ,The cleric passed on details of the warning, but ...
Cached Medicine News:Health News:MRI finds breast cancer before it becomes dangerous 2Health News:MRI finds breast cancer before it becomes dangerous 3Health News:Survival differences by race most apparent in advanced stages of breast cancer 2Health News:Researchers Discover How Cancer Evades the Immune System 2Health News:First Baby Born from Eggs Matured and Frozen in the Lab 2Health News:Those Who Cure can Kill Dire Prophesy of the doctors Plot 2
... solution tricompartmental total knee prosthesis stems from ... State-of-the-art design and manufacturing technologies have been ... function as well as a favorable pressure ... to keep wear to a minimum. The ...
... was designed for patients with difficult problems ... custom designs to repair difficult anatomic conditions. ... which reduces the chance of dislocation in ... been streamlined and updated so that the ...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively....
... knee prosthesis stems from many years of ... manufacturing technologies have been used in order ... as a favorable pressure distribution pattern on ... to a minimum. The inherent design of ...
Medicine Products: